"Biological Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenously-synthesized compounds that influence biological processes not otherwise classified under ENZYMES; HORMONES or HORMONE ANTAGONISTS.
| Descriptor ID |
D001685
|
| MeSH Number(s) |
D23
|
| Concept/Terms |
Biological Factors- Biological Factors
- Factor, Biological
- Factors, Biological
- Biologic Agents
- Agents, Biologic
- Biologic Factors
- Factors, Biologic
- Factor, Biologic
- Biologic Factor
- Biological Agents
- Agents, Biological
- Biological Factor
|
Below are MeSH descriptors whose meaning is more general than "Biological Factors".
Below are MeSH descriptors whose meaning is more specific than "Biological Factors".
This graph shows the total number of publications written about "Biological Factors" by people in this website by year, and whether "Biological Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 2 |
| 2016 | 1 | 1 | 2 |
| 2017 | 11 | 9 | 20 |
| 2018 | 6 | 4 | 10 |
| 2019 | 5 | 6 | 11 |
| 2020 | 6 | 3 | 9 |
| 2021 | 4 | 1 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Biological Factors" by people in Profiles.
-
Role of Biological Agents in the Treatment of SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children. J Clin Rheumatol. 2022 03 01; 28(2):e381-e387.
-
The role of immunomodulatory medications in the treatment of COVID-19. Curr Opin Rheumatol. 2021 09 01; 33(5):431-445.
-
Safety of COVID-19 vaccines in patients with psoriasis undergoing therapy with anti-interleukin agents. Expert Opin Biol Ther. 2021 11; 21(11):1535-1537.
-
Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course. J Cosmet Dermatol. 2021 Oct; 20(10):3098-3102.
-
The use of biological agents in pregnant women affected by autoimmune disorders: Why we need more research of this neglected area. Pharmacol Res. 2021 09; 171:105786.
-
COVID-19 prevalence and outcomes in patients receiving biologic therapies at an infusion center in New York City. Clin Immunol. 2021 09; 230:108803.
-
Lower incidence of COVID-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapy. J Gastroenterol Hepatol. 2021 Nov; 36(11):3050-3055.
-
COVID-19: biologic and immunosuppressive therapy in gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol. 2021 10; 18(10):705-715.
-
Microalgae: therapeutic potentials and applications. Mol Biol Rep. 2021 May; 48(5):4757-4765.
-
Mesenchymal Stromal Cell Secretome for Post-COVID-19 Pulmonary Fibrosis: A New Therapy to Treat the Long-Term Lung Sequelae? Cells. 2021 05 14; 10(5).